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PHeart Rhythm Disorders
Inappropriate Implantable Cardioverter-
Defibrillator Shocks in MADIT II
Frequency, Mechanisms, Predictors, and Survival Impact
James P. Daubert, MD,* Wojciech Zareba, MD, PHD,* David S. Cannom, MD,† Scott McNitt, MS,*
Spencer Z. Rosero, MD,* Paul Wang, MD,‡ Claudio Schuger, MD,§ Jonathan S. Steinberg, MD,
Steven L. Higgins, MD,¶ David J. Wilber, MD,# Helmut Klein, MD,** Mark L. Andrews, BBA,*
W. Jackson Hall, PHD,†† Arthur J. Moss, MD,* for the MADIT II Investigators
Rochester and New York, New York; Los Angeles, Stanford, and La Jolla, California; Detroit, Michigan;
Maywood, Illinois; and Magdeburg, Germany
Objectives This study sought to identify the incidence and outcome related to inappropriate implantable cardioverter-
defibrillator (ICD) shocks, that is, those for nonventricular arrhythmias.
Background The MADIT (Multicenter Automatic Defibrillator Implantation Trial) II showed that prophylactic ICD implantation
improves survival in post-myocardial infarction patients with reduced ejection fraction. Inappropriate ICD shocks
are common adverse consequences that may impair quality of life.
Methods Stored ICD electrograms from all shock episodes were adjudicated centrally. An inappropriate shock episode
was defined as an episode during which 1 or more inappropriate shocks occurred; another inappropriate ICD
episode occurring within 5 min was not counted. Programmed parameters for patients with and without inappro-
priate shocks were compared.
Results One or more inappropriate shocks occurred in 83 (11.5%) of the 719 MADIT II ICD patients. Inappropriate shock
episodes constituted 184 of the 590 total shock episodes (31.2%). Smoking, prior atrial fibrillation, diastolic hy-
pertension, and antecedent appropriate shock predicted inappropriate shock occurrence. Atrial fibrillation was
the most common trigger for inappropriate shock (44%), followed by supraventricular tachycardia (36%), and
then abnormal sensing (20%). The stability detection algorithm was programmed less frequently in patients re-
ceiving inappropriate shocks (17% vs. 36%, p  0.030), whereas other programming parameters did not differ
significantly from those without inappropriate shocks. Importantly, patients with inappropriate shocks had a
greater likelihood of all-cause mortality in follow-up (hazard ratio 2.29, p  0.025).
Conclusions Inappropriate ICD shocks occurred commonly in the MADIT II study, and were associated with increased risk of
all-cause mortality. (J Am Coll Cardiol 2008;51:1357–65) © 2008 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.09.073a
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Implantable cardioverter-defibrillator (ICD) therapy is
roven to reduce mortality (1–5). However, inappropriate
hocks for atrial arrhythmias with rapid ventricular conduc-
ion (6,7) or for abnormal sensing (8–10) results in multiple
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edical Center, Rochester, New York; †Good Samaritan Hospital, Los Angeles,
alifornia; ‡Stanford University Medical Center, Stanford, California; §Henry Ford
ealth System, Detroit, Michigan; St. Luke’s-Roosevelt Hospital Center, New
ork, New York; ¶Scripps Memorial Hospital, La Jolla, California; #Loyola
niversity Medical Center, Maywood, Illinois; **University Hospital, Magdeburg,
ermany; and the ††Department of Biostatistics, University of Rochester Medical
enter, Rochester, New York. Supported by a research grant from Guidant
orporation, St. Paul, Minnesota, to The University of Rochester Medical Center.p
Manuscript received February 21, 2007; revised manuscript received September 19,
007, accepted September 23, 2007.dverse effects (11–14) including impaired quality of life
15), psychiatric disturbances (16), and even provocation of
onfatal (17) or fatal (18) ventricular arrhythmia. Although
nappropriate shocks have been studied in some ICD groups
19,20), no reports have detailed inappropriate ICD therapy
See page 1366
n a pure primary prevention group like those in the
ADIT II study.
ethods
CD devices and programming. The MADIT II protocol
ermitted implantation of U.S. Food and Drug Adminis-
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or dual-chamber Guidant ICDs.
Each ICD stored intracardiac
electrograms for arrhythmia epi-
sodes. Moreover, each unit of-
fered 2 algorithms intended to
minimize inappropriate shocks:
1) “stability,” evaluating the reg-
ularity of the tachyarrhythmia;
and 2) “sudden onset,” the degree
to which the arrhythmia began
suddenly versus gradually (21).
The dual-chamber devices pro-
vided additional algorithms eval-
uating the atrial rate (22). The
ICD programming, including
such discriminator usage, was left
to the discretion of the investiga-
ors using standard clinical practice.
CD therapy event analysis. The MADIT II study ran-
omly allocated 742 patients to the ICD arm, but 1 withdrew
onsent and 22 never received an ICD, leaving 719 that could
e evaluated for inappropriate shocks. The ICDs were inter-
ogated quarterly and after ICD shocks. The ICD therapy was
efined as either antitachycardia pacing (ATP) or ICD shock.
wo investigators (J.P.D, W.Z.) categorized the rhythm
rompting ATP or shock using the stored electrograms.
ny ICD therapy not delivered for VT or VF was deemed
nappropriate, and the rhythm triggering therapy catego-
ized as: atrial fibrillation or atrial flutter (AF), supraven-
ricular including sinus tachycardia (SVT), or inappropriate
ensing using published criteria (9,19). A small percentage
f rhythms triggering ICD therapy (2.2%) were unclassified
ecause of missing or incomplete data. An episode’s termi-
ation was defined by the ICD re-detecting sinus rhythm
nd thus could include more than 1 shock (and/or ATP
ursts). As done previously in the AVID (Antiarrhythmics
ersus Implantable Defibrillators) study, a subsequent epi-
ode beginning 5 min after episode termination was
gnored for this analysis (19). Thus, an inappropriate shock
pisode was defined as an episode during which one or more
nappropriate shocks occurred; a separate ICD episode of
he same type (inappropriate or appropriate) occurring 5
in later was not counted.
tatistical analysis. Clinical characteristics were compared
sing the Wilcoxon rank sum test for continuous variables.
he chi-square test was used for dichotomous variables,
xcept the Fisher exact test was used when 25% or more of
he cells had expected cell counts fewer than 5 (sudden and
onsudden cardiac death). The Kaplan-Meier life-table
ethod was used to graphically display the time to first
vent and calculate the cumulative event rates for each group
nd within each group by risk factors. The results were
ompared using the log-rank statistic.
Using printouts or ICD discs downloaded after an inap-
Abbreviations
and Acronyms
AF  atrial fibrillation or
atrial flutter
ATP  antitachycardia
pacing
CHF  congestive heart
failure
HR  hazard ratio
ICD  implantable
cardioverter-defibrillator
SVT  supraventricular
tachycardia
VF  ventricular fibrillation
VT  ventricular
tachycardiaropriate shock prompted interrogation, the major tachyar- nhythmia detection settings were compared for the 83
nappropriate shock patients to 83 randomly chosen subjects
ithout inappropriate shock. The latter group was matched
ith the inappropriate shock group for the presence or
bsence of 3 variables associated with inappropriate shock,
rior atrial fibrillation, smoking, and appropriate shock.
heoretically 8 combinations of these 3 variables existed. In
eality, only 7 combinations of these 3 variables contained
atients who had received an inappropriate shock. Next,
rom the pool of patients who did not receive an inappropriate
hock, we randomly chose the same number of patients from
ach of the 7 groups defined by having the same combination
f these 3 characteristics. A stratified difference-between-
roportions test, with strata weights inversely proportional to
ariances, was used to derive p values for the binary variables.
he Mann-Whitney rank statistic, likewise stratified, was used
or the numerical variables. Unstratified versions were also
arried out to evaluate consistency of findings.
Using the 83 patients who did experience an inappropriate
hock and the 636 patients who did not experience inappro-
riate shocks, Cox proportional hazards regression models
ere developed to determine what factors predicted time to
nappropriate shock. Similarly, again using the patients with
nd without inappropriate shock, Cox proportional hazards
egression models were developed to determine whether the
ccurrence of inappropriate shocks predicted time to all-cause
ortality. Variables from the clinical characteristics table that
et the criteria of p value0.20 were considered as candidates
or the regression model of inappropriate shock. For the
nappropriate shock end point, appropriate shock was modeled
s a time-dependent covariate.
Both appropriate and inappropriate shock were modeled as
ime-dependent covariates in the all-cause mortality model.
dditional commonly used risk factors were included in this
odel. Follow-up time began at ICD implantation. Unclassi-
ed rhythms (n 13, 2.2% of total shocks) were not included
n this analysis.
The statistical software used for the analyses was SAS
ersion 9.13 (SAS Institute Inc., Cary, North Carolina). A
-sided probability value of 0.05 identified statistical
ignificance.
esults
ncidence and type of inappropriate shocks—or ATP.
ne or more inappropriate ICD shocks occurred in 83 of
19 patients (11.5%). After 2 years of follow-up, patients
ad a 13% likelihood of having experienced one or more
nappropriate shocks (Fig. 1). Table 1 shows patient expe-
ience with inappropriate and appropriate shocks. Thirty-
wo patients had more than 1 inappropriate shock episode
Table 1), ranging up to a maximum of 16 inappropriate
hock episodes during 18 months of follow-up for 1 patient.
atients experiencing an inappropriate shock had a mean
umber of 2.2  2.5 inappropriate shock episodes.
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April 8, 2008:1357–65 Inappropriate ICD Shocks in the MADIT II StudyTable 2 delineates the inappropriate shocks by episode
ather than by patient and shows the subclassification of
nappropriate shock by mechanism. As noted above, shock
pisodes were counted and multiple shocks within an
pisode were not tallied, nor were episodes caused by the
ame mechanism beginning within 5 min of a prior episode
Figure 1 Survival Free of Inappropriate Shock/Therapy
(A) The cumulative proportion of patients who experienced a first inappropriate
shock (due to any mechanism) is plotted versus time. (B) The cumulative pro-
portion of patients who experienced a first inappropriate therapy, antitachycar-
dia pacing (ATP) or shock (due to any mechanism) is plotted versus time. The
number of patients at risk at a given time point of follow-up is indicated below
the x axis. The proportion of the population experiencing the event in question
is given in parentheses at the 1-, 2-, and 3-year time points.
atients Experiencing Inappropriate ICD Shocks
Table 1 Patients Experiencing Inappropriate ICD Shocks
Shock Therapy Group Patients (n) Percent
One or more inappropriate shock episodes 83 11.5
1 inappropriate shock episode 51 7.1
2–4 inappropriate shock episodes 23 3.2
5 inappropriate shock episodes 9 1.3
Both inappropriate and appropriate shock episodes 27 3.8
Inappropriate but not appropriate shock episode(s) 56 7.8
No inappropriate shock episodes 636 88.5
Appropriate shock episode(s) 101 14.1
No appropriate shock episodes 535 74.4
Total patients 719 100.0
hock episodes consisted of an ICD detection during which 1 or more shocks occurred; episodes
aused by the same type of arrhythmia beginning within 5min of another episode were not counted
r reanalyzed.
ICD  implantable cardioverter-defibrillator.19). Table 2 thus reflects separate ICD shock episodes
ather than the total number of shocks. Atrial fibrillation or
trial flutter was the most common mechanism for inappro-
riate shock, followed by SVT, with inappropriate sensing
he least common mechanism for inappropriate shock in the
ADIT II study. The time-dependent occurrence of a
atient’s first inappropriate shock caused by any of the 3
echanisms is shown in Figure 2, illustrating that the time
ourse of the occurrence of the 3 types of inappropriate
hocks is similar. In the cohort of 719 patients with ICDs
ncluded in this analysis, 79 (11.0%) of patients had one type
f inappropriate shock, 3 (0.4%) had 2 types of inappropri-
te shock mechanism, and 1 (0.1%) of the patients experi-
nced ICD shock for all 3 types of inappropriate therapy
echanism.
We analyzed the heart rate at the time of a patient’s first
nappropriate shock for either AF or SVT. Inappropriate
ensing episodes were excluded from this analysis only,
Figure 2 Time-Dependent Occurrence
of Inappropriate Shock by Type
The cumulative proportion of patients experiencing a first inappropriate (Inapp.)
shock due to the 3 subcategories of inappropriate shock is plotted with
respect to time. The number of patients at risk at a given time point of fol-
low-up is indicated below the x axis. The proportion of the population experi-
encing the event in question is given in parentheses at the 1-, 2-, and 3-year
time points. AF  atrial fibrillation or atrial flutter; ICD  implantable cardio-
verter-defibrillator; SVT  supraventricular tachycardia.
hythm Responsible for ICD Shock Episodes
Table 2 Rhythm Responsible for ICD Shock Episodes
Shock Type Shock Episodes (n) Percent
Appropriate 393 66.6
Inappropriate 184 31.2
Atrial fibrillation/flutter 81 13.7
SVT 67 11.4
Abnormal sensing 36 6.1
Unclassified 13 2.2
Total 590 100.0
his table analyzes shock episodes from the standpoint of shock rather than by patient; a given
atient could receive 1 or more inappropriate shock(s) (from any or all of the subcategories) and/or
ne or more appropriate shock(s). Shock episodes consisted of an ICD detection during which 1 or
ore shock(s) occurred; episodes caused by the same type of arrhythmia beginning within 5 min
f another episode were not counted or reanalyzed.
ICD  implantable cardioverter-defibrillator; SVT  supraventricular tachycardia.
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Inappropriate ICD Shocks in the MADIT II Study April 8, 2008:1357–65ecause the true ventricular rate was actually normal for
hese, and not what the device reported. The mean ventric-
lar rate triggering inappropriate shock for AF or SVT was
74  22 beats/min (Fig. 3). The number of patients
xperiencing inappropriate shock at a given rate is shown
n the y axis. For instance, 3 patients had a (first)
nappropriate shock for atrial fibrillation with a heart rate
f 200 beats/min, and 1 patient had a heart rate of 200
eats/min because of SVT prompting inappropriate
hock. At the time of inappropriate shock, the ventricular
ate exceeded 160 beats/min in 78% of episodes.
Considering any inappropriate therapy, that is inap-
ropriate shock or ATP, this occurred in 100 of 719
13.9%) patients (Fig. 1B), of whom 17 patients experi-
nced inappropriate ATP therapy without having at least
 inappropriate shock during follow-up.
linical characteristics of patients receiving inappropri-
te ICD shocks. Inappropriate shock recipients differed
tatistically from nonrecipients (Table 3) for 3 baseline
linical characteristics: 1) prior atrial fibrillation (18.1% vs.
.4%, p  0.001), 2) smoking history (89.2% vs. 78.4%, p 
.022), and 3) diastolic blood pressure 80 mm Hg (37.3%
s. 26.3%, p  0.033). Considering interim events, appro-
riate therapy occurred more commonly in the inappropri-
te shock group than in those without inappropriate shocks
42.2% vs. 21.1%, p  0.001). Notably, the proportion of
atients receiving a dual-chamber ICD in the inappropriate
hock group versus those without inappropriate shock was
ot appreciably different (Table 3), suggesting that dual-
Figure 3 Ventricular Rate Precipitating Inappropriate Shock
The heart rate at the time of the ICD detection resulting in a patient’s first inappro
episodes are shown with cross-hatched bars, and SVT episodes are shown with s
device has by definition misconstrued the actual ventricular rate (typically normal i
as in figure 2.hamber ICD systems were not less prone to inappropriate
hocks in MADIT II.
Cox proportional hazards analysis found the baseline
haracteristics of prior atrial fibrillation (hazard ratio [HR]
.90, p  0.01), smoking history (HR 2.18, p  0.03), and
iastolic blood pressure 80 (HR 1.61, p  0.04) indepen-
ently predicted the occurrence of inappropriate shock
Table 4). Considering time-dependent factors, prior in-
erim appropriate shock predicted the occurrence of an
nappropriate shock (HR 2.25, p  0.03), as did interim
trial fibrillation (HR 3.45, 95% confidence interval 1.55 to
.69, p  0.01).
rogrammed parameters in patients with inappropriate
hocks. The SVT–VT discriminator stability function had
een activated less frequently in inappropriate shock recip-
ents (17%) than in those not receiving inappropriate shocks
36%, p  0.030). Among dual-chamber devices, a trend
oward the VA criterion being used less frequently was
een in patients with inappropriate shocks (31% vs. 50%,
 0.054). We did not observe other significant differences
n these parameters, such as the lowest zone detection rate
Table 5).
mpact of inappropriate shocks on outcomes. Inappro-
riate shock recipients tended to have a higher percent
otal mortality than those patients not experiencing
nappropriate shocks (16.9% vs. 12.9%, p  0.317, Table
). Because appropriate shock occurrence was one pre-
ictor of inappropriate shocks (Table 4), Cox propor-
ional hazards regression analysis was used to evaluate the
shock is shown in the bar graph in groups of 10 beats/min. Atrial fibrillation
rs. Inappropriate shocks caused by abnormal sensing are excluded because the
e cases). The events relate to shocks, not patients, in this figure. Abbreviationspriate
olid ba
n thes
i
(
d
a
i
(
p
e
T
s
p
4
s

o
n
a
I
C
p
re; ICD
P
O
b
i
A
s
7
1361JACC Vol. 51, No. 14, 2008 Daubert et al.
April 8, 2008:1357–65 Inappropriate ICD Shocks in the MADIT II Studyndependent survival impact of inappropriate ICD shocks
Table 6). In multivariate analysis, mortality was pre-
icted by blood urea nitrogen 25 (HR 2.07, p  0.01),
Clinical Characteristics of Patients With Versus
Table 3 Clinical Characteristics of Patients
Clinical Characteristic
No Inapp
n 
Characteristics at baseline
Age at randomization 65 yrs
Female gender
History of smoking
Canadian Class Angina Grade II to IV
NYHA functional CHF class II to IV
Prior coronary bypass surgery
History of diabetes
Atrial fibrillation
Heart rate 80 beats/min
Systolic blood pressure 130 mm Hg
Diastolic blood pressure 80 mm Hg
QRS 0.12 s
Left bundle branch block (yes/no)
Right bundle branch block (yes/no)
Blood urea nitrogen 25
Ejection fraction 0.25
Medications at baseline
Beta-blocker therapy
ACE inhibitor therapy
Angiotensin receptor blocker therapy
Statin therapy
Characteristics/events after enrollment
Dual-chamber ICD implanted*
Appropriate ICD therapy
CHF requiring hospitalization
CHF requiring hospitalization or death
Angina or MI requiring hospitalization
Death during follow-up
Cardiac death (total)†
Cardiac death, sudden†
Cardiac death, nonsudden†
*A dual-chamber or single-chamber device was implanted at the in
modified Hinkle-Thaler classification.
ACE  angiotensin-converting enzyme; CHF  congestive heart failu
NYHA  New York Heart Association.
redictors of Inappropriate Shock by Coxopor ional Hazards Regressi n Analysis
Table 4 Predictors of Inappropriate Shock by CoxProportional Hazards Regression Analysis
Variable
Hazard
Ratio
95% Confidence
Interval p Value
Baseline characteristics
Atrial fibrillation 2.90 1.65–5.09 0.01
Smoking 2.18 1.09–4.35 0.03
Diastolic blood pressure 80 mm Hg 1.61 1.03–2.52 0.04
Interim events
Interim appropriate shock 2.25 1.09–4.67 0.03
ther covariates tested but not found significant in multivariate analysis included absence of
eta-blocker therapy, prior coronary artery bypass graft procedure, blood urea nitrogen 25, and
nterim hospitalization for either congestive heart failure, myocardial infarction, or unstable angina.
n alternative analysis that also included interim atrial fibrillation found this to be a highlye
ignificant predictor of inappropriate shock (hazard ratio 3.45, 95% confidence interval 1.55 to
.69, p  0.01); the other variables remained significant.bsence of beta-blocker therapy (HR 1.64, p  0.02), and
nterim congestive heart failure (CHF) hospitalization
HR 4.23, p  0.01) Because inappropriate and appro-
riate shocks were intertwined in their occurrence, we
xamined them independently and together (Table 6).
he occurrence of both inappropriate and appropriate
hock was associated with an over 4-fold increase in
robability of mortality for a given follow-up period (HR
.08, p  0.01). The occurrence of an inappropriate
hock was associated with an HR for mortality of 2.29 (p
0.02). Prior appropriate shock alone portended an HR
f 3.36 for mortality (p  0.01). On the other hand,
either appropriate nor inappropriate ATP was associ-
ted with a significant mortality increase (Table 6).
nappropriate shocks were not a predictor of subsequent
HF hospitalization (data not shown), although appro-
riate shocks were identified as a predictor of CHF
out Inappropriate ICD Shock
Versus Without Inappropriate ICD Shock
e Shock
%)
Inappropriate Shock
n  83 (%) p Value
59.0 0.263
12.0 0.346
89.2 0.022
27.7 0.864
64.6 0.802
49.4 0.081
28.9 0.318
18.1 0.001
36.1 0.175
31.3 0.417
37.3 0.033
33.7 0.301
14.1 0.235
9.0 0.991
20.7 0.091
49.4 0.722
57.8 0.204
84.3 0.118
7.2 0.093
63.9 0.980
38.6 0.313
42.2 0.001
26.8 0.436
35.4 0.230
18.1 0.210
16.9 0.317
8.4 0.495
4.9 0.518
2.4 0.215
tor’s discretion. †A blinded committee adjudicated deaths using a
 implantable cardioverter-defibrillator; MI  myocardial infarction;With
With
ropriat
636 (
52.5
16.0
78.4
28.6
66.0
59.4
34.4
7.4
28.9
35.8
26.3
39.6
19.7
9.0
29.7
47.3
64.9
76.7
13.8
64.0
44.4
21.1
23.0
28.9
13.1
12.9
10.9
3.3
6.5
vestigavents as previously reported (23).
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nappropriate shock epidemiology. In the MADIT II
tudy, inappropriate ICD shocks were common, occurring
n 11.5% of patients and with a cumulative 1- and 2-year
vent rate of 10% and 13%, respectively (Fig. 1A). Overall,
84 inappropriate shock episodes occurred compared with a
otal of 393 appropriate shock episodes. An AF caused
4.0% of inappropriate shock episodes; SVT and inappro-
riate sensing were less common.
Frequent inappropriate ICD shocks and ATP occurred in
ther series (7,19,20), such as the AVID study with 20% of
atients experiencing an inappropriate shock or ATP in
ollow-up and 9% by 2 years of follow-up (19). Enrolling
atients with prior sustained VT or VF, a higher proportion
f patients experienced appropriate therapy, so the overall
ercent of events that were inappropriate was lower in the
VID study. Swerdlow et al. (24) had previously predicted
hat the proportion of inappropriate shocks of the total
ICD Programming in Patients With and Without
Table 5 ICD Programming in Patients With
Programming
Ina
Single-chamber and dual-chamber devices
Number of patients
Lowest VT zone (beats/min) 16
Lowest VT zone detection time (s) 2
Stability on, % (n)
Sudden onset on, % (n)
Dual-chamber devices only
Number of patients
VA on, % (n)
Atrial fibrillation discriminator on, % (n)
*p values from stratified Mann-Whitney rank test and difference-betwe
Values were consistent with corresponding ones from nonstratified tes
shocks, matching on history of atrial fibrillation, smoking, and approp
ICD  implantable cardioverter-defibrillator; VT  ventricular tachyc
Predictors of All-Cause Mortality by Cox Proport
Table 6 Predictors of All-Cause Mortality by
Variable Hazard
Baseline characteristics
Blood urea nitrogen 25 2.0
No beta-blocker 1.6
Interim events
Interim CHF hospitalization 4.2
Appropriate and inappropriate shock 4.0
Appropriate shock only 3.3
Inappropriate shock only 2.2
Appropriate and inappropriate therapy 3.1
Appropriate therapy only 2.5
Inappropriate therapy only 2.0
Appropriate ATP but not shock 0.4
Inappropriate ATP but not shock 0.7
Other covariates that were evaluated but not found significant predict
Heart Association class at baseline 2, prior non–coronary artery b
duration 0.12 s, prior angina, history of atrial arrhythmia, diabetes
130 mm Hg, left bundle branch block, and interim myocardial infa
when present, is not adjusted for in this model.
ATP  antitachycardia pacing; CHF congestive heart failure.hock count would be higher in primary prevention ICD
atients because of a lower appropriate shock rate. Enrolling
diverse ICD population, the Pain Free Study found that
5% of patients experienced inappropriate therapy (20),
ith the proportion of all events being inappropriate trend-
ng higher in the primary prevention subset than in the
econdary prevention group (46% vs. 34%, p  0.09)
20). In the Multicenter InSync ICD Randomized Clin-
cal Evaluation (MIRACLE ICD) study, 32% of primary
revention biventricular ICD patients had inappropriate
etections, although not all of these led to shocks, and
nlike in the MADIT II study and most studies, inap-
ropriate detections for sinus tachycardia exceeded atrial
rrhythmias (19,20,25,26).
nappropriate shocks: root causes. Inappropriate shock
atients more commonly had a history of atrial fibrillation,
moking, and/or diastolic hypertension and were more likely
o also have had a prior appropriate ICD shock (Table 3).
ropriate ICD Shocks
ithout Inappropriate ICD Shocks
iate No Inappropriate
Shock p Value*
83†
19.9 171.9 14.5 0.540
1.99 2.42 2.07 0.830
) 36 (30) 0.030
) 23 (19) 0.160
36
) 50 (18) 0.054
) 44 (16) 0.210
ortions test, for continuous and dichotomized measures, respectively.
lected randomly from among the 635 patients without inappropriate
ock; see text for details.
Hazards Regression Analysis
Proportional Hazards Regression Analysis
95% Confidence Interval p Value
1.38–3.11 0.01
1.09–2.47 0.02
2.70–6.62 0.01
1.71–9.75 0.01
2.04–5.55 0.01
1.11–4.71 0.02
1.38–7.03 0.01
1.54–4.15 0.01
0.97–4.13 0.06
0.148–1.150 0.0903
0.213–2.496 0.6145
uded atrial fibrillation, smoking, congestive heart failure, New York
graft revascularization, diastolic blood pressure 80 mm Hg, QRS
us, age 65 years, ejection fraction 0.25, systolic blood pressure
unstable angina. The effect of a second appropriate shock episode,Inapp
and W
ppropr
Shock
83
9.3
.45
17 (14
16 (13
32
31 (10
34 (11
en-prop
ts. †Seional
Cox
Ratio
7
4
3
8
6
9
2
3
1
12
29
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April 8, 2008:1357–65 Inappropriate ICD Shocks in the MADIT II Studylter et al. (27) reported that young age and nonischemic
ardiomyopathy predicted inappropriate shocks. Other in-
estigators have found that prior history of atrial fibrillation
nd appropriate therapy were predictors of inappropriate
hocks, similar to our findings (26). Because AF was the
ost common inappropriate shock mechanism, its associa-
ion as a predictive factor is expected. Smoking was recently
ound to increase the incidence of both appropriate and
nappropriate shocks in the MADIT II study, possibly
ecause of a myriad of adverse consequences such as sympa-
hetic stimulation, increased platelet reactivity, vasoconstric-
ion, endothelial dysfunction, and tachycardia (28). Hyper-
ension is a potent risk factor for AF and may act in this way
o promote the likelihood of an inappropriate shock. The
ink between appropriate and inappropriate therapy likely
tems from a combination of several factors: 1) ventricular
rrhythmia or its treatment (ATP or shock) provoking atrial
brillation (29,30); 2) inappropriate therapy causing VT,
hat is, proarrhythmia (18,27); 3) a common factor or
actors predisposing to both VT/VF and AF or SVT; or 4)
ncorrect categorization of some appropriate episodes in a
iven patient as inappropriate or vice versa.
utcomes of patients experiencing inappropriate shocks.
he prior occurrence of an inappropriate shock was associ-
ted with a doubled risk of total mortality in this study even
fter accounting for the known association between appro-
riate shock and increased mortality (23) (Table 6). Possible
xplanations for the increased mortality in the cohort with
nappropriate shocks include: 1) potential direct mechanical,
rrhythmic, or hemodynamic adverse effect of the shocks
hemselves, such as fatal proarrhythmia (18,27) or other
ffects (11); and 2) baseline characteristics or interim events,
uch as AF, causing both inappropriate shocks and an
ncreased risk of mortality. Because shocks bore a greater
ssociation with mortality than ATP (Table 6), explanation
ne may be favored. However, an alternative inference is
hat a more recalcitrant, persistent, rapid, or recurrent
rrhythmia may have led to a shock, whereas a brief flurry of
he arrhythmia may have led to ATP and not required a
hock.
mplications for minimizing inappropriate therapy. We
ound a statistically different, lower utilization rate of the
tability SVT–VT discriminator in patients with inappro-
riate shocks compared with patients not having inappro-
riate shocks, raising the possibility that more aggressive use
f the available SVT discriminators could reduce the inci-
ence of inappropriate detection. Stability was used in a
inority of the overall population (Table 5), likely reflecting
tandard clinical practice at the time of this study. The
VT–VT discriminator usage carries the theoretical risk of
nderdetection of true ventricular arrhythmias, although
urrent data suggest that underdetection due to stability
sage is infrequent (9,21,31,32). Nevertheless, the stability
iscriminator’s effectiveness in preventing therapy for atrial
brillation is markedly reduced at rates above 170 beats/min
9). In fact, Figure 3 shows that most of the rapidly oonducted atrial fibrillation episodes causing inappropriate
hocks were indeed 170 beats/min or faster. Thus, even if
his discriminator had been uniformly programmed, it may
ot have had a major impact. Other parameters were not
tatistically different in the 2 groups, further arguing against
rogramming aberrations explaining the inappropriate
hocks (Table 5). Although programming a higher detec-
ion rate likely reduces the detection of atrial arrhythmias
nd misinterpretation of them as ventricular arrhythmias, it
s clear that programming too high a rate cutoff could lead
o underdetection of relatively slow monomorphic VTs or
nderdetection of polymorphic ventricular arrhythmias or
entricular fibrillation due to intermittent undersensing
31,33,34). Although there is an incidence of sudden death
n any ICD population, the extent to which this could have
een prevented by the ICD or whether some of these
udden deaths are caused by underdetection of ventricular
rrhythmias remains unknown.
Dual-chamber ICD systems were used approximately as
ommonly in patients who experienced an inappropriate
hock (38.6%) as in those who did not (44.4%, Table 3).
rior studies have often failed to show a benefit of dual-
hamber devices in preventing inappropriate detections of
upraventricular arrhythmias (22,26,35,36). The Detect Su-
raventricular Tachycardia Study (DETECT SVT) recently
howed a reduction in the percent of total SVT episodes
hat were inappropriately classified as VT in the dual-
hamber detection group (30.9%) than the single-chamber
roup (39.5%) (37). However, this means that almost
ne-third of the SVT episodes were still misclassified
espite the dual-chamber criteria, and furthermore that
otal inappropriate shocks were not reduced in the
ual-chamber arm (37,38). Future enhancements of
VT–VT discrimination systems may yield improve-
ents (9,33,38 – 42).
The role of medications in preventing inappropriate
hocks is mixed, with a prior study failing to find beta-
locker therapy protective from inappropriate shocks in the
ADIT II study (43). However, sotalol and amiodarone
ave reduced inappropriate shocks by as much as 78% in a
econdary prevention population (27,44,45). Recently intro-
uced continuous wireless ICD monitoring (46,47) could
educe inappropriate therapies.
tudy limitations. Total shocks were not counted, but
ather ICD episodes containing one or more shocks were
allied. The potential additional prognostic importance of
he total number of shocks cannot be evaluated. The ICD
rogramming was not protocol specified, and although the
T cutoff rate was collected prospectively, the other param-
ters analyzed (Table 5) were obtained retrospectively, and
he difference in stability programming must be interpreted
autiously. Moreover, parameter changes and possible ef-
ects on inappropriate shocks could not be analyzed in a
ime-dependent fashion. Electrogram interpretation to ad-
udicate appropriate versus inappropriate shocks was based
n available data, which differs for single-chamber and
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ation may occur (49). This MADIT II substudy’s findings
ay not pertain to other ICD populations. Lastly, although
uality of life data were collected in MADIT II and initial
nalysis has been performed (50), the association of inap-
ropriate shocks and quality of life is not yet available.
onclusions
nappropriate shocks were common in the MADIT II
tudy, as in other recently reported trials, occurring in 83
11.5%) of the 719 MADIT II ICD patients and consti-
uting 31.2% of all shock episodes. Smoking, atrial fibrilla-
ion, diastolic hypertension, and prior appropriate shocks
ere associated with an increased chance of inappropriate
hock. Inappropriate shock occurrence was associated with
ncreased probability of mortality in follow-up. Coupled
ith potential effects on quality of life, this association with
ncreased mortality heightens the importance of efforts to
educe the occurrence of inappropriate shocks.
cknowledgments
he investigators acknowledge the invaluable assistance of
s. Jodie Palma in the review of inappropriate shock
lectrograms and device programming and of Mr. Thomas
oss in preparation of the manuscript.
eprint requests and correspondence: Dr. James P. Daubert, Box
79-URMC, Rochester, New York 14642. E-mail: James_
aubert@URMC.Rochester.edu.
EFERENCES
1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Inves-
tigators. A Comparison of Antiarrhythmic-Drug Therapy with Im-
plantable Defibrillators in Patients Resuscitated from Near-Fatal
Ventricular Arrhythmias. N Engl J Med 1997;337:1576–83.
2. Buxton A, Lee K, Fisher J, et al. A randomized study of the prevention
of sudden death in patients with coronary artery disease. N Engl J Med
1999;341:1882–90.
3. Moss AJ, Zareba W, Hall WJ. Prophylactic implantation of a
defibrillator in patients with myocardial infarction and reduced ejec-
tion fraction. N Engl J Med 2002;348:877–83.
4. Bardy GH, Lee KL, Mark DB, et al., and the Sudden Cardiac Death
in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an
implantable cardioverter-defibrillator for congestive heart failure.
N Engl J Med 2005;352:225–37.
5. Kadish A, Dyer A, Daubert JP, et al., for the Defibrillators in
Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFI-
NITE) Investigators. Prophylactic defibrillator implantation in
patients with nonischemic dilated cardiomyopathy. N Engl J Med
2004;350:2151– 8.
6. Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival
in 241 patients with implantable cardioverter-defibrillator therapy.
Circulation 1993;87:1880–8.
7. Rosenqvist M, Beyer T, Block M, et al. Adverse events with trans-
venous implantable cardioverter-defibrillators: a prospective multi-
center study. Circulation 1998;98:663–70.
8. Kron J. Clinical significance of device-related complications in clinical
trials and implications for future trials: insights from the Antiarrhyth-
mics Versus Implantable Defibrillators (AVID) trial. Card Electro-
physiol Rev Cardiovasc Med 2003;7:473–8.9. Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: part I.
Pacing Clin Electrophysiol 2005;28:1322–46.0. Gold MR, Peters RW, Johnson JW, et al. Complications associated
with pectoral implantation of cardioverter defibrillators. Pacing Clin
Electrophysiol 1997;20:208–11.
1. Epstein AE, Kay GN, Plumb VJ, et al. Gross and microscopic
pathological changes associated with nonthoracotomy implantable
defibrillator leads. Circulation 1998;98:1517–24.
2. Avitall B, Port S, Gal R, et al. Automatic implantable cardioverter/
defibrillator discharges and acute myocardial injury. Circulation 1990;
81:1482–7.
3. Finkelmeier B, Kenwood N, Summers C. Psychological ramifications
of surviving sudden cardiac death. Crit Care Q 1984;1:71–9.
4. Luderitz B, Jung W, Deister A, et al. Patient acceptance of the
implantable cardioverter defibrillator in ventricular tachyarrhythmias.
Pacing Clin Electrophysiol 1993;16:1815–21.
5. Schron EB, Exner DV, Yao Q, et al. Quality of Life in the
Antiarrhythmics Versus Implantable Defibrillators Trial. Impact of
therapy and influence of adverse symptoms and defibrillator shocks.
Circulation 2002;105:589–94.
6. Prudente LA. Phantom shock in a patient with an implantable
cardioverter defibrillator: case report. Am J Crit Care 2003;12:144–6.
7. Jones G, Johnson G, Troutman C. Incidence of atrial fibrillation
following ventricular defibrillation with transvenous lead systems in
man. J Cardiovasc Electrophysiol 1992;3:411–7.
8. Vollmann D, Luthje L, Vonhof S, et al. Inappropriate therapy and
fatal proarrhythmia by an implantable cardioverter-defibrillator. Heart
Rhythm 2005;2:307–9.
9. Klein RC, Raitt MH, Wilkoff BL, et al. Analysis of implantable
cardioverter defibrillator therapy in the Antiarrhythmics Versus Im-
plantable Defibrillators (AVID) trial. J Cardiovasc Electrophysiol
2003;14:940–8.
0. Sweeney MO, Wathen MS, Volosin K, et al. Appropriate and
inappropriate ventricular therapies, quality of life, and mortality among
primary and secondary prevention implantable cardioverter defibrilla-
tor patients: results from the Pacing Fast VT REduces Shock ThEra-
pies (PainFREE Rx II) trial. Circulation 2005;111:2898–905.
1. Higgins SL, Lee RS, Kramer RL. Stability: an ICD detection criterion
for discriminating atrial fibrillation from ventricular tachycardia. J Car-
diovasc Electrophysiol 1995;6:1081–8.
2. Kuhlkamp V, Dornberger V, Mewis C, et al. Clinical experience with
the new detection algorithms for atrial fibrillation of a defibrillator
with dual chamber sensing and pacing. J Cardiovasc Electrophysiol
1999;10:905–15.
3. Moss AJ, Greenberg H, Case RB, et al., for the Multicenter Auto-
matic Defibrillator Implantation Trial-II (MADIT-II) Research
Group. Long-term clinical course of patients after termination of
ventricular tachyarrhythmia by an implanted defibrillator. Circulation
2004;110:3760–5.
4. Swerdlow CD, Cannom DS. Supraventricular tachycardia–ventricular
tachycardia discrimination algorithms in implantable cardioverter de-
fibrillators: state-of-the-art review. J Cardiovasc Electrophysiol 2001;
12:606–12.
5. Wilkoff BL, Hess M, Young J, et al. Differences in tachyarrhythmia
detection and implantable cardioverter defibrillator therapy by primary
or secondary prevention indication in cardiac resynchronization ther-
apy patients. J Cardiovasc Electrophysiol 2004;15:1002–9.
6. Theuns D, Klootwijk A, Simoons M, et al. Clinical variables predict-
ing inappropriate use of implantable cardioverter-defibrillator in pa-
tients with coronary heart disease or nonischemic dilated cardiomyop-
athy. Am J Cardiol 2005;95:271–4.
7. Alter P, Waldhans S, Plachta E, et al. Complications of implantable
cardioverter defibrillator therapy in 440 consecutive patients. Pacing
Clin Electrophysiol 2005;28:926–32.
8. Goldenberg I, Moss AJ, McNitt S, et al. Cigarette smoking and the
risk of supraventricular and ventricular tachyarrhythmias in high-risk
cardiac patients with implantable cardioverter defibrillators. J Cardio-
vasc Electrophysiol 2006;17:931–6.
9. Johnson NJ, Marchlinski FE. Arrhythmias induced by device anti-
tachycardia therapy due to diagnostic nonspecificity. J Am Coll
Cardiol 1991;18:1418–25.
0. Florin TJ, Weiss DN, Peters RW, et al. Induction of atrial fibrillation
with low-energy defibrillator shocks in patients with implantable
cardioverter defibrillators. Am J Cardiol 1997;80:960–2.
33
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
1365JACC Vol. 51, No. 14, 2008 Daubert et al.
April 8, 2008:1357–65 Inappropriate ICD Shocks in the MADIT II Study1. Swerdlow CD, Ahern T, Chen PS, et al. Underdetection of ventricular
tachycardia by algorithm to enhance specificity in a tiered therapy
cardioverter defibrillator. J Am Coll Cardiol 1994;24:416–24.
2. Glikson M, Swerdlow CD, Gurevitz OT, et al. Optimal combination
of discriminators for differentiating ventricular from supraventricular
tachycardia by dual-chamber defibrillators. J Cardiovasc Electrophysiol
2005;16:732–9.
3. Bansch D, Steffgen F, Gronefeld G, et al. The 11 Trial: a
prospective trial of a dual- versus a single-chamber implantable
defibrillator in patients with slow ventricular tachycardias. Circulation
2004;110:1022–9.
4. LeFranc P, Kus T, Vinet A, et al. Underdetection of ventricular
tachycardia using a 40 ms stability criterion: effect of antiarrhythmic
therapy. Pacing Clin Electrophysiol 1997;20:2882–92.
5. Deisenhofer I, Kolb C, Ndrepepa G, et al. Do current dual chamber
cardioverter defibrillators have advantages over conventional single
chamber cardioverter defibrillators in reducing inappropriate therapies?
A randomized, prospective study [see comment]. J Cardiovasc Elec-
trophysiol 2001;12:134–42.
6. Hintringer F, Schwarzacher S, Eibl G, et al. Inappropriate detection of
supraventricular arrhythmias by implantable dual chamber defibrilla-
tors: a comparison of four different algorithms. Pacing Clin Electro-
physiol 2001;24:835–41.
7. Friedman PA, McClelland RL, Bamlet WR, et al. Dual-chamber
versus single-chamber detection enhancements for implantable defi-
brillator rhythm diagnosis: the Detect Supraventricular Tachycardia
Study. Circulation 2006;113:2871–9.
8. Sweeney MO. Overcoming the defects of a virtue: dual-chamber
versus single-chamber detection enhancements for implantable defi-
brillator rhythm diagnosis: the Detect Supraventricular Tachycardia
Study. Circulation 2006;113:2862–4.
9. Wilkoff BL, Kuhlkamp V, Volosin K, et al. Critical analysis of
dual-chamber implantable cardioverter-defibrillator arrhythmia detec-
tion: results and technical considerations. Circulation 2001;103:
381–6.
0. Ridley DP, Gula LJ, Krahn AD, et al. Atrial response to ventricular
antitachycardia pacing discriminates mechanism of 1:1 atrioventricular
tachycardia. J Cardiovasc Electrophysiol 2005;16:601–5.
1. Berger RD, Lerew DR, Smith JM, et al. The Rhythm ID Going Head
to Head Trial (RIGHT): design of a randomized trial comparingcompetitive rhythm discrimination algorithms in implantable
cardioverter defibrillators. J Cardiovasc Electrophysiol 2006;17:749–
53.
2. Saba S, Gorodeski R, Yang S, et al. Use of correlation waveform
analysis in discrimination between anterograde and retrograde atrial
electrograms during ventricular tachycardia [see comment]. J Cardio-
vasc Electrophysiol 2001;12:145–9.
3. Brodine WN, Tung RT, Lee JK, et al. Effects of beta-blockers on
implantable cardioverter defibrillator therapy and survival in the
patients with ischemic cardiomyopathy (from the Multicenter Auto-
matic Defibrillator Implantation Trial-II). Am J Cardiol 2005;96:
691–5.
4. Pacifico A, Hohnloser SH, Williams JH, et al. Prevention of
implantable-defibrillator shocks by treatment with sotalol. d,l–Sotalol
Implantable Cardioverter-Defibrillator Study Group [comment].
N Engl J Med 1999;340:1855–62.
5. Connolly SJ, Dorian P, Roberts RS, et al. Optimal pharmacological
therapy in cardioverter defibrillator patients I. Comparison of beta-
blockers, amiodarone plus beta-blockers, or sotalol for prevention of
shocks from implantable cardioverter defibrillators: the OPTIC Study:
a randomized trial [see comment]. JAMA 2006;295:165–71.
6. Res J, Theuns D, Jordaens L. The role of remote monitoring in the
reduction of inappropriate implantable cardioverter defibrillator ther-
apies. Clin Res Cardiol 2006;95:iii17–21.
7. Schoenfeld MH, Compton SJ, Mead RH, et al. Remote monitoring of
implantable cardioverter defibrillators: a prospective analysis [see
comment]. Pacing Clin Electrophysiol 2004;27:757–63.
8. Lee KL, Lau CP. Inappropriate defibrillator therapies: are dual
chamber devices providing a remedy [comment]? J Cardiovasc Elec-
trophysiol 2001;12:143–4.
9. Hallett N, Monahan K, Casavant D, et al. Inadequacy of qualitative
implantable cardioverter defibrillator electrogram analysis to distin-
guish supraventricular from ventricular tachycardia due to electrogram
changes during normally conducted complexes. Pacing Clin Electro-
physiol 1997;20:1723–6.
0. Piotrowicz K, Noyes K, Lyness JM, et al. Physical functioning and
mental well-being in association with health outcome in patients
enrolled in the Multicenter Automatic Defibrillator Implantation Trial
II. Eur Heart J 2007;28:601–7.
